Sign in
4

Changes in Ownership

Atara Biotherapeutics, Inc. Filed Acc 0001140361-22-019981

EVP, Head of R&D sold 3,873 shares at $5.32 ($20,597)

From the SEC's structured data for this filing

Trades in this filing

Dupont Jakob · EVP, Head of R&D

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-17 Sale : show line 1 in the form −3,873 $5.32 $20,597 163,006 D
Open-market sales · 3,873 sh · avg $5.32 · $20,597
Loading xslF345X03/form4.xml…